Adequate peri-implant and periodontal soft tissue volume and quality are increasingly recognized as key determinants of long-term treatment success. Tissue thickness, the width of keratinized tissue, and vascular supply all contribute to marginal bone preservation, resistance to inflammatory complications, predictable wound healing, and long-term esthetic outcomes around teeth and implants. While autogenous connective tissue grafts remain the clinical gold standard for soft tissue augmentation, their routine use is limited by donor-site morbidity, increased surgical time, limited tissue availability, and technique-sensitive harvesting procedures. These challenges become even more relevant when treating multiple sites or patients seeking minimally invasive treatment options.